Induction Radiation Therapy for Esophageal Cancer: Does Dose Affect Outcomes?

被引:12
|
作者
Semenkovich, Tara R. [1 ]
Samson, Pamela P. [2 ]
Hudson, Jessica L. [3 ]
Subramanian, Melanie
Meyers, Bryan F.
Kozower, Benjamin D. [1 ]
Kreisel, Daniel [1 ]
Patterson, G. Alexander [1 ]
Robinson, Clifford G. [2 ]
Bradley, Jeffrey D. [2 ]
Puri, Varun [1 ]
机构
[1] Washington Univ, Div Cardiothorac Surg, Dept Surg, St Louis, MO 63110 USA
[2] Washington Univ, Dept Radiat Oncol, St Louis, MO 63110 USA
[3] Washington Univ, Dept Cardiothorac Surg, 660 S Euclid Ave,Campus Box 8234, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
PHASE-III TRIAL; RANDOMIZED-TRIAL; CHEMORADIOTHERAPY; SURGERY; CHEMOTHERAPY; RADIOTHERAPY;
D O I
10.1016/j.athoracsur.2018.09.064
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Wide variation is seen in the dosage of preoperative induction radiation therapy for esophageal cancer. We investigated associations between outcomes after esophagectomy and dosage of induction radiation therapy. Methods. Patients undergoing induction radiation therapy (30 to 70 Gy), followed by esophagectomy, were identified from the National Cancer Database and classified as low (<40 Gy), standard (40 to 50.4 Gy), and high dose (>50.4 Gy). Perioperative outcomes and overall survival were compared. Subgroup analysis compared two common dosages: 45 Gy and 50.4 Gy. Results. From 2004 to 2014, 10,738 patients (84.7%) received standard-dose radiation, increasing from 69.7% in 2004 to 93.6% in 2014 (p < 0.001), 1,329 (10.5%) received low-dose radiation, and 608 (4.8%) received high-dose radiation. Higher rates of pathologic complete response (pCR; low: 11.7%, standard: 16.2%, high: 21.0%; p < 0.001) and downstaging (low: 52.0%, standard: 56.4%, high: 63.1%, p = 0.001) were observed as the dosage increased. On multivariable analysis, compared with standard-dose, high-dose radiation was associated with higher 30-day mortality (odds ratio [OR], 2.11; p < 0.001) without a higher likelihood of downstaging or pCR. Low-dose radiation was associated with lower likelihood of downstaging (OR, 0.85; p = 0.04) and pCR (OR, 0.67; p < 0.001) without lowering the risk of 30-day mortality. The dose of 50.4 Gy was associated with higher likelihood of pCR (OR, 1.12; p = 0.04), without affecting 30-day mortality, compared with 45 Gy. Conclusions. High-dose induction radiation (>50.4 Gy) is associated with increased perioperative death after esophagectomy, without a significant improvement in tumor response. Low-dose radiation (<30 Gy) is associated with worse tumor response without a lower risk of perioperative death. Within standard dosages, 50.4 Gy is associated with higher likelihood of pCR without adversely affecting perioperative mortality compared with 45 Gy. (C) 2019 by The Society of Thoracic Surgeons
引用
收藏
页码:903 / 911
页数:9
相关论文
共 50 条
  • [41] The clinical outcomes of elderly esophageal cancer patients who received definitive chemoradiotherapy
    Lu, Hao-Wei
    Chen, Chien-Chih
    Chen, Hsin-Hua
    Yeh, Hui-Ling
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (10) : 906 - 910
  • [42] Single-Dose Radiation Therapy for Localized Prostate Cancer: Where Does the Evidence Lead?
    Cozzi, Salvatore
    Lazrek, Amina
    Rubini, Giuseppe
    Rubini, Dino
    Sardaro, Angela
    Houabes, Sarah
    Laude, Cecile
    Gassa, Frederic
    Bardoscia, Lilia
    Roukoz, Camille
    CANCERS, 2025, 17 (07)
  • [43] Race Does Not Affect Survival in Patients With Prostate Cancer Treated With Radiation Therapy
    Kodiyan, Joyson
    Ashamalla, Mark
    Guirguis, Adel
    Ashamalla, Hani
    ANTICANCER RESEARCH, 2020, 40 (06) : 3307 - 3314
  • [44] Preoperative therapy in locally advanced esophageal cancer
    Garg, Pankaj Kumar
    Sharma, Jyoti
    Jakhetiya, Ashish
    Goel, Aakanksha
    Gaur, Manish Kumar
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (39) : 8750 - 8759
  • [45] Definitive, Preoperative, and Palliative Radiation Therapy of Esophageal Cancer
    Fokas, Emmanouil
    Roedel, Claus
    VISZERALMEDIZIN, 2015, 31 (05): : 347 - 353
  • [46] Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities
    Zaorsky, Nicholas G.
    Keith, Scott W.
    Shaikh, Talha
    Nguyen, Paul L.
    Horwitz, Eric M.
    Dicker, Adam P.
    Den, Robert B.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (04): : 409 - 415
  • [47] Induction Therapy Does Not Improve Survival for Clinical Stage T2N0 Esophageal Cancer
    Speicher, Paul J.
    Ganapathi, Asvin M.
    Englum, Brian R.
    Hartwig, Matthew G.
    Onaitis, Mark W.
    D'Amico, Thomas A.
    Berry, Mark F.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (08) : 1195 - 1201
  • [48] Meta-Analysis for the Therapeutic Effect of Neoadjuvant Therapy in Resectable Esophageal Cancer
    Zhu, Yusen
    Liu, Min
    Yun, Xiaojing
    Wang, Dongmei
    Bai, Yuhuan
    Zhang, Guizhi
    Ji, Bei
    Jing, Changchun
    PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (03) : 657 - 663
  • [49] Radiation therapy for limited-stage small-cell esophageal cancer
    Nemoto, K
    Zhao, HJ
    Goto, T
    Ogawa, Y
    Takai, Y
    Matsushita, H
    Takeda, K
    Takahashi, C
    Saito, H
    Yamada, S
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (04): : 404 - 407
  • [50] Predictive factors for acute radiation pneumonitis in postoperative intensity modulated radiation therapy and volumetric modulated arc therapy of esophageal cancer
    Zhao, Yaqin
    Chen, Lu
    Zhang, Shu
    Wu, Qiang
    Jiang, Xiaoqin
    Zhu, Hong
    Wang, Jin
    Li, Zhiping
    Xu, Yong
    Zhang, Ying Jie
    Bai, Sen
    Xu, Feng
    THORACIC CANCER, 2015, 6 (01) : 49 - 57